Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fang, Yi ^a,b   Feng, Youjun ^c   Wu, Tongjin ^a   Srinivas, Swaminath ^c   Yang, Weiqiang ^a   Fan, Jue ^a   Yang, Chi ^a   Wang, Shihua ^a  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; BETA CATENIN; MICRORNA; MICRORNA 33A; MYC PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; MIRN33 MICRORNA, HUMAN; POISON; RNA; TUMOR PROTEIN; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL STRAIN HEPG2; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HELA CELL; METABOLISM; NEOPLASM; PATHOLOGY; WNT SIGNALING PATHWAY; DRUG EFFECTS; HELA CELL LINE; HEPG2 CELL LINE; NEOPLASMS;

3' UNTRANSLATED REGIONS; AFLATOXIN B1; BETA CATENIN; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HEP G2 CELLS; HUMANS; MICRORNAS; NEOPLASM PROTEINS; NEOPLASMS; POISONS; RNA, NEOPLASM; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84883202156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073004     Document Type: Article

References (54)

1. Strosnider H, Azziz-Baumgartner E, Banziger M, Bhat RV, Breiman R, et al. (2006) Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ Health Perspect 114: 1898-1903. PubMed: 17185282.
2. Mejía-Teniente L, Chapa-Oliver AM, Vazquez-Cruz MA, Torres-Pacheco I, Guevara-González RG, Aflatoxins Biochemistry and Molecular Biology-Biotechnological Approaches for Control in Crops.
3. Prince LO, Campbell TC, (1982) Effects of sex difference and dietary protein level on the binding of aflatoxin B1 to rat liver chromatin proteins in vivo. Cancer Res 42: 5053-5059. PubMed: 6814751.
4. Montesano R, Hainaut P, Wild CP, (1997) Hepatocellular carcinoma: from gene to public health. J Nar Cancer Inst 89: 1844-1851. PubMed: 9414172.
5. Peterson S, Lampe JW, Bammler TK, Gross-Steinmeyer K, Eaton DL, (2006) Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1. Food Chem Toxicol 44: 1474-1484. doi:10.1016/j.fct.2006.04.010. PubMed: 16762476.
6. Ball RW, Huie JM, Coulombe RA, (1995) Comparative activation of aflatoxin B1 by mammalian pulmonary tissues. Toxicol Lett 75: 119-125. doi:10.1016/0378-4274(94)03169-8. PubMed: 7863518.
7. Gallagher EP, Kunze KL, Stapleton PL, Eaton DL, (1996) The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 141: 595-606. doi:10.1006/taap.1996.0326. PubMed: 8975785.
8. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, et al. (1998) Activation and detoxication of aflatoxin B1. Mutat Res 402: 121-128. doi:10.1016/S0027-5107(97)00289-3. PubMed: 9675258.
9. Raney VM, Harris TM, Stone MP, (1993) DNA conformation mediates aflatoxin B1-DNA binding and the formation of guanine N7 adducts by aflatoxin B18, 9-exo-epoxide. Chem Res Toxicol 6: 64-68. doi:10.1021/tx00031a010. PubMed: 8448352.
10. Yunus AW, Razzazi-Fazeli E, Bohm J, (2011) Aflatoxin B1 in Affecting Broiler's Performance, Immunity, and Gastrointestinal Tract: A Review of History and Contemporary Issues. Toxins 3: 566-590. doi:10.3390/toxins3060566. PubMed: 22069726.
11. Teufel A, Staib F, Kanzler S, Weinmann A, Schulze-Bergkamen H, et al. (2007) Genetics of hepatocellular carcinoma. World J Gatroenterol 13: 2271.
12. Chen Ban K, Singh H, Krishnan R, Fong Seow H, (2004) Comparison of the expression of β-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1. J Surg Oncol 86: 157-163. doi:10.1002/jso.20051. PubMed: 15170655.
13. Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, et al. (2001) CTNNB1 mutations and β-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol Carcinogen 31: 68-73. doi:10.1002/mc.1041.
14. Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, et al. (2007) Genomic stability prevails in North-African hepatocellular carcinomas. Dig Liver Dis 39: 671-677. doi:10.1016/j.dld.2007.03.012. PubMed: 17531558.
15. Pineau P, Marchio A, Battiston C, Cordina E, Russo A, et al. (2008) Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. Mutat Res 653: 6-13. doi:10.1016/j.mrgentox.2008.01.012. PubMed: 18467159.
16. Huang K, Zhang JX, Han L, You YP, Jiang T, et al. (2010) MicroRNA roles in beta-catenin pathway. Mol Cancer 9: 252. doi:10.1186/1476-4598-9-252. PubMed: 20858269.
17. Kumar M, Zhao X, Wang XW, (2011) Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell. J Biosci 1: 5.
18. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790. doi:10.1126/science.275.5307.1787. PubMed: 9065402.
19. Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP, (2009) Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 55: 307-317. doi:10.1016/j.neuint.2009.03.016. PubMed: 19576519.
20. Pu P, Zhang Z, Kang C, Jiang R, Jia Z, et al. (2008) Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 16: 351-361. PubMed: 18949017.
21. Magrelli A, Azzalin G, Salvatore M, Viganotti M, Tosto F, et al. (2009) Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol 2: 157-163. PubMed: 19701500.
22. Braeuning A, Sanna R, Huelsken J, Schwarz M, (2009) Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1. Drug Metab Dispos 37: 1138-1145. doi:10.1124/dmd.108.026179. PubMed: 19237511.
23. Bernstein E, Caudy AA, Hammond SM, Hannon GJ, (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-365. doi:10.1038/35053110. PubMed: 11201747.
24. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, et al. (2001) Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing. Cell 106: 23-34. doi:10.1016/S0092-8674(01)00431-7. PubMed: 11461699.
25. Burge CB, Nielsen CB, (2008) Mammalian gene regulation through the 3'UTR. Massachusetts Institute of Technology.
26. Veronese A, Visone R, Consiglio J, Acunzo M, Lupini L, et al. (2011) Mutated β-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A 108: 4840-4845. doi:10.1073/pnas.1101734108. PubMed: 21383185.
27. Wang J, Liu X, Wu H, Ni P, Gu Z, et al. (2010) CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 38: 5366-5383. doi:10.1093/nar/gkq285. PubMed: 20423907.
28. Rossi JJ, (2011) A novel nuclear miRNA mediated modulation of a non-coding antisense RNA and its cognate sense coding mRNA. EMBO J 30: 4340-4341. doi:10.1038/emboj.2011.373. PubMed: 22048334.
29. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770. doi:10.1038/ng1590. PubMed: 15965474.
30. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591. doi:10.1016/j.cell.2009.02.005. PubMed: 19239879.
31. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144. doi:10.1093/nar/gkj430. PubMed: 16381832.
32. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773. doi:10.1038/nature03315. PubMed: 15685193.
33. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36. doi:10.1016/S0092-8674(03)00231-9. PubMed: 12679032.
34. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. doi:10.1016/j.cell.2009.01.002. PubMed: 19167326.
35. Iorio MV, Croce CM, (2012) Causes and Consequences of MicroRNA Dysregulation. Cancer J 18: 215-222. doi:10.1097/PPO.0b013e318250c001. PubMed: 22647357.
36. Wuchty S, Arjona D, Bozdag S, Bauer PO, (2012) Involvement of microRNA families in cancer. Nucleic Acids Res 40: 8219-8226. doi:10.1093/nar/gks627. PubMed: 22743268.
37. Zhu Y, Lu Y, Zhang Q, Liu JJ, Li TJ, et al. (2012) MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 40: 4615-4625. doi:10.1093/nar/gkr1278. PubMed: 22210897.
38. Liang L, Wong CM, Ying Q, Fan DNY, Huang S, et al. (2010) MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 52: 1731-1740. doi:10.1002/hep.23904. PubMed: 20827722.
39. Xia H, Ng SS, Jiang S, Cheung WKC, Sze J, et al. (2010) miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 391: 535-541. doi:10.1016/j.bbrc.2009.11.093. PubMed: 19931509.
40. Xia H, Cheung WKC, Sze J, Lu G, Jiang S, et al. (2010) miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and β-catenin signaling. J Biol Chem 285: 36995-37004. doi:10.1074/jbc.M110.133744. PubMed: 20826811.
41. Saydam O, Shen Y, Würdinger T, Senol O, Boke E, et al. (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/β-catenin signaling pathway. Mol Cell Biol 29: 5923-5940. doi:10.1128/MCB.00332-09. PubMed: 19703993.
42. Eaton DL, Gallagher EP, (1994) Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol 34: 135-172. doi:10.1146/annurev.pa.34.040194.001031. PubMed: 8042848.
43. Yang X-J, Lu H-Y, Li Z-Y, Bian Q, Qiu L-L, et al. (2012) Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology 300: 138-148. doi:10.1016/j.tox.2012.06.010. PubMed: 22743290.
44. Ma Y, Kong Q, Hua H, Luo T, Jiang Y, (2012) Aflatoxin B1 Up-Regulates Insulin Receptor Substrate 2 and Stimulates Hepatoma Cell Migration. PLOS ONE 7: e47961. doi:10.1371/journal.pone.0047961. PubMed: 23112878.
45. Bianco G, Russo R, Marzocco S, Velotto S, Severino L, (2012) Modulation of macrophage activity by aflatoxins B1 and B2 and their metabolites aflatoxins M1 and M2. Toxicon 59: 644-650. doi:10.1016/j.toxicon.2012.02.010. PubMed: 22402176.
46. McGlynn KA, London WT, (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Cl Ga 19: 3-23.
47. Fuster JJ, Andrés V, (2010) A role for miR-33 in p53 regulation: New perspectives for hematopoietic stem cell research. Cell Cycle 9: 3401-3400. doi:10.4161/cc.9.17.13073. PubMed: 20703094.
48. Herrera-Merchan A, Cerrato C, Luengo G, Dominguez O, Piris MA, et al. (2010) miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 9: 3277-3285. doi:10.4161/cc.9.16.12598. PubMed: 20703086.
49. Ho PC, Chang KC, Chuang YS, Wei LN, (2011) Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J 25: 1758-1766. doi:10.1096/fj.10-179267. PubMed: 21285396.
50. Hu W, Coller J, (2012) What comes first: translational repression or mRNA degradation? The deepening mystery of microRNA function. Cell Res 22: 1322-1324.
51. Huntzinger E, Izaurralde E, (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110. doi:10.1038/nrg2936. PubMed: 21245828.
52. Coller J, Parker R, (2005) General translational repression by activators of mRNA decapping. Cell 122: 875-886. doi:10.1016/j.cell.2005.07.012. PubMed: 16179257.
53. Mazumder B, Seshadri V, Fox PL, (2003) Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28: 91-98. doi:10.1016/S0968-0004(03)00002-1. PubMed: 12575997.
54. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179-e179. doi:10.1093/nar/gni178. PubMed: 16314309.